Thyrocare Tech. - Thyrocare Technologies Share Price

Thyrocare Tech. - Thyrocare Technologies Share Price

  • 532.80-15.16 (-2.77%)
  • Closed
  • As On: 10 Jun, 2026, 03:59 PM IST
Loading...
Open546.55
High559.00
Low530.00
Prev Close547.95
Volume3,36,527
VWAP(₹)542.91

Key Metrics

PE Ratio(x)52.01
EPS - TTM(₹)10.24
MCap(₹ Cr.)8,480.33
MCap Rank18
PB Ratio(x)14.88
Div Yield(%)2.63
Face Value(₹)10.00
52W High(₹)578.25
52W Low(₹)316.78
MCap/Sales6.71
Beta(1 Month)0.58
BV/Share(₹)36.82

Thyrocare Tech. share price insights

  • Dividend Announcement

    Company announced a dividend of Rs 7.0 per share on May 7, 2026 with record date of Jun 23, 2026.
  • ROE Outperforming 5 Year Average

    Company delivered ROE of 27.84% in year ending Mar 31, 2026 outperforming its 5 year avg. of 20.8%. (Source: Consolidated Financials)
  • Beating 3 Yr Revenue CAGR

    Company's annual revenue growth of 20.49% outperformed its 3 year CAGR of 16.32%. (Source: Consolidated Financials)
  • Employee & Interest Expense

    Company has spent less than 1% of its operating revenues towards interest expenses and 16.65% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Thyrocare Tech. Share Price Update

    Thyrocare Technologies Ltd. share price moved down by -2.77% from its previous close of Rs 547.95. Thyrocare Technologies Ltd. stock last traded price is 532.80

    Share PriceValue
    Today/Current/Last532.80
    Previous Day547.95

Found Insights useful?

Thyrocare Tech. Share Price Returns

1 Day-2.77%
1 Month9.52%
3 Months42.35%
1 Year60.61%
3 Years240.27%
5 Years43.44%

Thyrocare Tech. Share Recommendations

Mean recosCurrent
STRONG BUY

4 Analysts

Strong
Sell
SellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy2222
Buy2211
Hold----
Sell----
Strong Sell----
# Analysts4433
Recent Recos
  • Target₹725
  • OrganizationICICI Securities
  • BUY
  • Target₹725
  • OrganizationICICI Securities
  • BUY
  • Target₹740
  • OrganizationICICI Securities
  • BUY

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income200.51219.58197.68191.75169.93
    Total Income Growth (%)-8.6811.083.0912.84-5.57
    Total Expenses165.49156.69146.67143.23141.25
    Total Expenses Growth (%)5.626.832.401.40-0.63
    EBIT35.0262.8951.0148.5228.68
    EBIT Growth (%)-44.3223.295.1369.18-24.17
    Profit after Tax (PAT)29.0147.9938.9321.7019.11
    PAT Growth (%)-39.5523.2779.4013.55-28.35
    EBIT Margin (%)17.4728.6425.8025.3016.88
    Net Profit Margin (%)14.4721.8619.6911.3211.25
    Basic EPS (₹)1.829.057.354.173.58
    Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
    Total Income185.91204.51182.85178.41156.06
    Total Income Growth (%)-9.0911.852.4914.32-5.52
    Total Expenses149.76143.02131.32130.01127.64
    Total Expenses Growth (%)4.718.911.011.862.77
    EBIT36.1561.4951.5348.4028.42
    EBIT Growth (%)-41.2119.336.4770.30-30.63
    Profit after Tax (PAT)26.1543.0336.0521.9519.10
    PAT Growth (%)-39.2319.3664.2414.92-35.44
    EBIT Margin (%)19.4430.0728.1827.1318.21
    Net Profit Margin (%)14.0721.0419.7212.3012.24
    Basic EPS (₹)1.648.126.804.083.53
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue702.18581.25535.09618.11507.05
    Total Revenue Growth (%)20.818.63-13.4321.9015.00
    Total Expenses555.30485.66447.68390.21354.51
    Total Expenses Growth (%)14.348.4814.7310.0720.40
    Profit after Tax (PAT)91.5170.7664.36176.14113.15
    PAT Growth (%)29.329.94-63.4655.6728.00
    Operating Profit Margin (%)21.8117.4417.0439.1031.01
    Net Profit Margin (%)13.3112.3712.2229.9122.87
    Basic EPS (₹)17.1313.4212.1633.3021.41
    FY 2025FY 2024FY 2023FY 2022FY 2021
    Total Revenue646.44531.20491.85568.93486.55
    Total Revenue Growth (%)21.698.00-13.5516.9318.53
    Total Expenses495.23432.98410.78361.55325.27
    Total Expenses Growth (%)14.385.4013.6211.1527.98
    Profit after Tax (PAT)95.7871.1456.97152.05119.77
    PAT Growth (%)34.6424.87-62.5326.9551.00
    Operating Profit Margin (%)24.2919.4517.1237.3534.14
    Net Profit Margin (%)15.1213.5711.7127.0725.25
    Basic EPS (₹)17.9513.4410.7728.7522.66

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Beating 3 Yr Revenue CAGR

      Company's annual revenue growth of 20.49% outperformed its 3 year CAGR of 16.32%. (Source: Consolidated Financials)
    • Employee & Interest Expense

      Company has spent less than 1% of its operating revenues towards interest expenses and 16.65% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets692.75643.88632.72607.66545.80
    Total Assets Growth (%)7.591.764.1211.3315.91
    Total Liabilities145.70116.2597.5081.09118.53
    Total Liabilities Growth (%)25.3319.2320.24-31.5913.71
    Total Equity547.05527.63535.22526.57427.27
    Total Equity Growth (%)3.68-1.421.6423.2416.54
    Current Ratio (x)2.773.083.544.192.50
    Total Debt to Equity (x)0.000.040.000.000.00
    Contingent Liabilities216.83299.65404.97156.92129.81
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Total Assets676.35620.27611.87597.17527.79
    Total Assets Growth (%)9.041.372.4613.1519.30
    Total Liabilities139.25106.4690.8376.4782.33
    Total Liabilities Growth (%)30.8017.2118.78-7.1228.32
    Total Equity537.10513.81521.04520.70445.46
    Total Equity Growth (%)4.53-1.390.0716.8917.77
    Current Ratio (x)2.693.233.223.832.91
    Total Debt to Equity (x)0.000.040.000.000.00
    Contingent Liabilities216.39299.65403.69-129.05

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities191.32167.63129.31113.41116.03
    Net Cash used in Investing Activities-52.52-91.28-38.99-23.57-50.23
    Net Cash flow from Financing Activities-130.42-84.81-86.18-89.41-61.56
    Net Cash Flow8.38-8.464.140.434.24
    Closing Cash & Cash Equivalent17.689.3017.7713.6313.20
    Closing Cash & Cash Equivalent Growth (%)90.11-47.6630.373.2647.32
    Total Debt/ CFO (x)0.000.130.000.000.00
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Net Cash flow from Operating Activities190.76155.19120.02105.68110.41
    Net Cash used in Investing Activities-54.70-80.29-31.65-12.32-53.19
    Net Cash flow from Financing Activities-124.44-83.71-87.50-86.91-57.05
    Net Cash Flow11.62-8.810.876.450.17
    Closing Cash & Cash Equivalent15.183.5612.3711.505.05
    Closing Cash & Cash Equivalent Growth (%)326.40-71.227.57127.723.48
    Total Debt/ CFO (x)0.000.130.000.000.00

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Decrease in Cash from Investing

      Company has used Rs 23.01 cr for investing activities which is an YoY decrease of 56.19%. (Source: Consolidated Financials)
  • AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)16.7313.4312.0433.4526.48
    Return on Capital Employed (%)26.2618.0316.1542.3934.03
    Return on Assets (%)13.2010.9810.1728.9820.73
    Interest Coverage Ratio (x)67.2834.9554.67111.45176.33
    Asset Turnover Ratio (x)1.030.900.800.9890.62
    Price to Earnings (x)39.5344.4435.4623.2642.19
    Price to Book (x)6.595.954.267.7711.17
    EV/EBITDA (x)17.3021.2417.4915.4425.90
    EBITDA Margin (%)29.8525.6624.3944.8537.13
    AnnualFY 2025FY 2024FY 2023FY 2022FY 2021
    Return on Equity (%)17.8313.8410.9329.2026.88
    Return on Capital Employed (%)27.2018.7315.4639.0734.81
    Return on Assets (%)14.1611.469.3125.4622.69
    Interest Coverage Ratio (x)76.1837.8252.18100.10245.36
    Asset Turnover Ratio (x)0.980.850.801.0089.85
    Price to Earnings (x)37.7444.2540.0026.9540.00
    Price to Book (x)6.716.104.377.8610.72
    EV/EBITDA (x)17.7322.1319.2317.1326.04
    EBITDA Margin (%)31.6426.9124.1342.4238.58
    Insights
    • ROE Outperforming 5 Year Average

      Company delivered ROE of 27.84% in year ending Mar 31, 2026 outperforming its 5 year avg. of 20.8%. (Source: Consolidated Financials)

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters9,69,69,69660.92 %0.00
    Pledge9,69,69,696100.00 %0.00
    FII85,47,0275.37 %0.41
    DII3,34,13,75721.00 %0.47
    MF3,09,52,42919.45 %0.84
    Others2,02,34,83512.70 %-0.88
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters60.9260.9371.0671.06
    Pledge100.00100.0085.84100.00
    FII5.374.964.853.23
    DII21.0020.5213.4714.54
    Mutual Funds19.4518.6011.8912.66
    Others12.7013.5910.6211.16

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Corporate Actions

  • General Meeting

    -

    Jun 05, 2026

    Final

    70%

    May 07, 2026

    Board Meeting

    Audited Results & Final Dividend

    Apr 29, 2026

  • Announced onMeeting on
    Apr 29, 2026May 07, 2026
    Audited Results & Final Dividend
    Jan 20, 2026Jan 28, 2026
    Quarterly Results
    Oct 06, 2025Oct 14, 2025
    Qtr Results, Int. Dividend & Bonus issue
    Jul 16, 2025Jul 23, 2025
    Quarterly Results
    Apr 16, 2025Apr 23, 2025
    Audited Results & Final Dividend
  • Announced onEx-DateDividend%
    May 07, 2026Jun 23, 202670%
    Oct 14, 2025Oct 24, 202570%
    Apr 23, 2025Jul 25, 2025210%
    May 14, 2024Aug 16, 2024180%
    Apr 10, 2023Apr 20, 2023180%
  • Announced onEx-Date
    Oct 14, 2025Nov 28, 2025
    Bonus Ratio: 2 share(s) for every 1 shares held
  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Jun 05, 2026Jun 30, 2026
    -
    Oct 16, 2025Nov 18, 2025
    -
    Aug 26, 2025Sep 28, 2025
    -
    Jul 07, 2025Jul 31, 2025
    -
    Dec 09, 2024Jan 13, 2025
    -

About Thyrocare Tech.

Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 8,480.33 Crore) operating in Hospitals & Allied Services sector.

Show More

Industry

Diagnostics

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty Microcap 250, BSE NEXT 500

Address

D/37-1, TTC Industrial Area,MIDC, Turbhe,New Mumbai, Maharashtra - 400703

Executive Leadership

RG

Rahul Guha

Chairman & M.D & CEO
AK

Alok Kumar Jagnani

Non Exe.Non Ind.Director
GV

Gaurav Verma

Non Exe.Non Ind.Director
UP

Uday Patel Kadam

Non Exe.Non Ind.Director
Show More

Auditors

MSKA & Associates
BSR & Co. LLP

FAQs about Thyrocare Tech. share

  • 1. What's the Thyrocare Tech. share price today?
    Thyrocare Tech. share price is Rs 532.80 as on 10 Jun, 2026, 03:59 PM IST. Thyrocare Tech. share price is down by 2.77% based on previous share price of Rs 541.35. Thyrocare Tech. share price trend:
    • Last 12 Months: Thyrocare Tech. share price moved up 60.61%
    • Last 3 Years: Thyrocare Tech. Share price moved up by 240.27%
  • 2. What are the returns for Thyrocare Tech. share?
    Return Performance of Thyrocare Tech. Shares:
    • 1 Week: Thyrocare Tech. share price moved up by 1.45%
  • 3. What's the market capitalization of Thyrocare Tech.?
    Within the Hospitals & Allied Services sector, Thyrocare Tech. stock has a market cap rank of 18. Thyrocare Tech. has a market cap of Rs 8,480.33 Cr.
  • 4. What is 52 week high/low of Thyrocare Tech. share price?
    Thyrocare Tech. share price saw a 52 week high of Rs 578.25 and 52 week low of Rs 316.78.
  • 5. What is the PE & PB ratio of Thyrocare Tech.?
    The PE ratio of Thyrocare Tech. stands at 53.49, while the PB ratio is 14.88.

Top Gainers

As on 03:59 PM | 10 Jun 2026
Inox India
1,891.60
204.90 (12.15%)
Akums Drugs & Pharma
592.10
43.86 (8.00%)
Chambal Fertilisers
477.65
22.90 (5.04%)
Afcons Infrastru
330.05
14.56 (4.62%)
Concord Biotech Ltd.
1,330.70
58.50 (4.60%)

Top Losers

As on 03:59 PM | 10 Jun 2026
Oil India Ltd
427.35
-48.60 (-10.22%)
IFCI
71.83
-5.24 (-6.80%)
Manappuram Finance
288.25
-19.00 (-6.19%)
Jindal Saw
225.16
-14.66 (-6.11%)
NLC India
309.60
-18.15 (-5.54%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.